Sorafenib

AXL receptor tyrosine kinase ; Homo sapiens







2 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35634427 AXL and MET in Hepatocellular Carcinoma: A Systematic Literature Review. 2022 Apr 1
2 30765873 Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma. 2019 Mar 10